A Clinical Evaluation of Two Contact Lenses Used With Three Care Systems

NCT ID: NCT04195581

Last Updated: 2021-06-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-16

Study Completion Date

2020-05-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study was to compare the clinical performance of the two contact lenses when used in combination with three care systems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This was a randomized, open-label, crossover study, controlled by cross-comparison. Subjects were randomized to wear each lens and solution combination for a month in random sequence; that is for a total of six months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Subjects will use each lens and solution combination for a month in random sequence for a total of six months.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

comfilcon A with Hy-Care Multi-purpose solution

Subjects were randomized to wear each lens and solution combination for a month.

Group Type EXPERIMENTAL

comfilcon A

Intervention Type DEVICE

Subjects were randomized to wear each lens and solution combination for a month.

comfilcon A with All in One Light Multi-purpose solution

Subjects were randomized to wear each lens and solution combination for a month.

Group Type EXPERIMENTAL

comfilcon A

Intervention Type DEVICE

Subjects were randomized to wear each lens and solution combination for a month.

comfilcon A with Refine One Step Hydrogen Peroxide Solution

Subjects were randomized to wear each lens and solution combination for a month.

Group Type EXPERIMENTAL

comfilcon A

Intervention Type DEVICE

Subjects were randomized to wear each lens and solution combination for a month.

fanfilcon A with Hy-Care Multi-purpose solution

Subjects were randomized to wear each lens and solution combination for a month.

Group Type ACTIVE_COMPARATOR

fanfilcon A

Intervention Type DEVICE

Subjects were randomized to wear each lens and solution combination for a month.

fanfilcon A with All in One Light multi-purpose solution

Subjects were randomized to wear each lens and solution combination for a month.

Group Type ACTIVE_COMPARATOR

fanfilcon A

Intervention Type DEVICE

Subjects were randomized to wear each lens and solution combination for a month.

fanfilcon A with Refine One Step Hydrogen Peroxide Solution

Subjects were randomized to wear each lens and solution combination for a month.

Group Type ACTIVE_COMPARATOR

fanfilcon A

Intervention Type DEVICE

Subjects were randomized to wear each lens and solution combination for a month.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

comfilcon A

Subjects were randomized to wear each lens and solution combination for a month.

Intervention Type DEVICE

fanfilcon A

Subjects were randomized to wear each lens and solution combination for a month.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. They are aged 18-50 and have capacity to volunteer.
2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
3. They are willing and able to follow the protocol.
4. They are an existing wearer of reusable, single vision, spherical soft contact lenses.
5. They have a contact lens spherical prescription between -1.00 to - 6.50D (inclusive)
6. They have a spectacle cylindrical correction of -1.00D or less in each eye.
7. At dispensing, they can attain at least 0.20 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range.
8. They are willing to comply with the wear schedule (at least five days per week and for at least eight hours per day).
9. They agree not to participate in other clinical research for the duration of the study.

Exclusion Criteria

1. They have an ocular disorder which would normally contra-indicate contact lens wear.
2. They have a systemic disorder which would normally contra-indicate contact lens wear.
3. They are using any topical medication such as eye drops or ointment.
4. They have had cataract surgery.
5. They have had corneal refractive surgery.
6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
7. They are pregnant or breastfeeding.
8. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
9. They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
10. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CooperVision, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philip Morgan, MCOptom FAAO FBCLA

Role: PRINCIPAL_INVESTIGATOR

Eurolens Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Manchester

Manchester, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C19-658 EX-MKTG-108

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.